Skip to Content

A5 (Iclusig 15 mg)

Generic Name: ponatinib

Pill with imprint A5 is White, Round and has been identified as Iclusig 15 mg. It is supplied by ARIAD Pharmaceuticals, Inc..

Iclusig is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia and belongs to the drug classes BCR-ABL tyrosine kinase inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A5

Iclusig

Generic Name:
ponatinib
Imprint:
A5
Strength:
15 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
ARIAD Pharmaceuticals, Inc.
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
silicon dioxide
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide